ATC Group: L01AD02 Lomustine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01AD02 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01A Alkylating agents
4 L01AD Nitrosoureas
5 L01AD02 Lomustine

Active ingredients in L01AD02

Active Ingredient Description
Lomustine

Lomustine’s mode of action is believed to be partly as an alkylating agent and partly by inhibition of several steps in the synthesis of nucleic acid and inhibition of the repair of single strand breaks in DNA chains.

Medicines in this ATC group

Brazil (BR)

Canada (CA)

Estonia (EE)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.